Lindsey Cass

1.5k total citations
37 papers, 1.0k citations indexed

About

Lindsey Cass is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lindsey Cass has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 12 papers in Epidemiology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lindsey Cass's work include Respiratory viral infections research (11 papers), Asthma and respiratory diseases (6 papers) and HIV/AIDS drug development and treatment (6 papers). Lindsey Cass is often cited by papers focused on Respiratory viral infections research (11 papers), Asthma and respiratory diseases (6 papers) and HIV/AIDS drug development and treatment (6 papers). Lindsey Cass collaborates with scholars based in United Kingdom, United States and Netherlands. Lindsey Cass's co-authors include Alan Bye, Constantin Efthymiopoulos, Amy Peng, Frederick G. Hayden, David P. Calfee, D. G. Harcourt, Richard Fritz, W. Gregory Alvord, Warren Strober and Stephen E. Straus and has published in prestigious journals such as Nature, American Journal of Respiratory and Critical Care Medicine and The Journal of Infectious Diseases.

In The Last Decade

Lindsey Cass

34 papers receiving 967 citations

Peers

Lindsey Cass
Kimberly Robins United States
Anne L. Hotard United States
R. J. Harris Australia
Hilda N. Rivera United States
D Blaškovič Slovakia
Ludmila V. Asher United States
Xiaowang Qu China
Catherine M. Bendel United States
Gardner Middlebrook United States
E Balestra Italy
Kimberly Robins United States
Lindsey Cass
Citations per year, relative to Lindsey Cass Lindsey Cass (= 1×) peers Kimberly Robins

Countries citing papers authored by Lindsey Cass

Since Specialization
Citations

This map shows the geographic impact of Lindsey Cass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindsey Cass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindsey Cass more than expected).

Fields of papers citing papers by Lindsey Cass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lindsey Cass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindsey Cass. The network helps show where Lindsey Cass may publish in the future.

Co-authorship network of co-authors of Lindsey Cass

This figure shows the co-authorship network connecting the top 25 collaborators of Lindsey Cass. A scholar is included among the top collaborators of Lindsey Cass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lindsey Cass. Lindsey Cass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cass, Lindsey, John Ayrton, Roger J. M. Brüggemann, et al.. (2025). In vitro and clinical data demonstrate negligible risk of drug–drug interactions with opelconazole, a novel inhaled antifungal agent. Journal of Antimicrobial Chemotherapy. 80(12). 3391–3400. 2 indexed citations
2.
3.
Murray, Alison D., Lindsey Cass, Kazuhiro Ito, et al.. (2020). PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections. Journal of Fungi. 6(4). 373–373. 31 indexed citations
4.
Thwaites, Ryan S., Matthew Coates, Kazuhiro Ito, et al.. (2018). Reduced Nasal Viral Load and IFN Responses in Infants with Respiratory Syncytial Virus Bronchiolitis and Respiratory Failure. American Journal of Respiratory and Critical Care Medicine. 198(8). 1074–1084. 72 indexed citations
5.
Cass, Lindsey, Amanda Davis, Alison D. Murray, et al.. (2018). 1335. Safety and Pharmacokinetic Profile of PC786, a Novel Inhibitor of Respiratory Syncytial Virus L-protein Polymerase, in a Single and Multiple-Ascending Dose Study in Healthy Volunteer and Mild Asthmatics. Open Forum Infectious Diseases. 5(suppl_1). S407–S408. 6 indexed citations
6.
Thwaites, Ryan S., Kazuhiro Ito, Matthew Coates, et al.. (2017). Nasosorption as a Minimally Invasive Sampling Procedure: Mucosal Viral Load and Inflammation in Primary RSV Bronchiolitis. The Journal of Infectious Diseases. 215(8). 1240–1244. 27 indexed citations
7.
Cass, Lindsey, Kazuhiro Ito, Catherine E. Charron, et al.. (2013). Safety, pharmacokinetic and pharmacodynamic profile of RV568, a narrow spectrum kinase inhibitor, following repeat inhaled dosing in COPD patients. European Respiratory Journal. 42(Suppl 57). 1971–1971. 4 indexed citations
8.
9.
Moore, Katy H. P., Lindsey Cass, Nigel Dallow, et al.. (2001). Pharmacokinetics and Tolerability of GW420867X, a Nonnucleoside Reverse Transcriptase Inhibitor, following Single Escalating Doses in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 41(10). 1098–1105. 1 indexed citations
10.
Cass, Lindsey, et al.. (2001). The Bioavailability of the Novel Nonnucleoside Reverse Transcriptase Inhibitor GW420867X Is Unaffected by Food in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 41(5). 528–535. 23 indexed citations
11.
Arastéh, Keikawus, Robin Wood, Markus Müller, et al.. (2001). GW420867X Administered to HIV-1-Infected Patients Alone and in Combination with Lamivudine and Zidovudine. HIV Clinical Trials. 2(4). 307–316. 11 indexed citations
12.
Moore, Katy H. P., Lindsey Cass, Nigel Dallow, et al.. (2001). Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitor. European Journal of Clinical Pharmacology. 56(11). 805–811. 7 indexed citations
13.
Cass, Lindsey, Kulasiri A. Gunawardena, Mark MacMahon, & Alan Bye. (2000). Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir. Respiratory Medicine. 94(2). 166–173. 33 indexed citations
14.
Thomas, Sarah, Lindsey Cass, William Prince, & M. B. Segal. (2000). Brain and CSF entry of the novel nonnucleoside reverse transcriptase inhibitor, GW420867X. Neuroreport. 11(17). 3811–3815. 3 indexed citations
15.
Fritz, Richard, Frederick G. Hayden, David P. Calfee, et al.. (1999). Nasal Cytokine and Chemokine Responses in Experimental Influenza A Virus Infection: Results of a Placebo‐Controlled Trial of Intravenous Zanamivir Treatment. The Journal of Infectious Diseases. 180(3). 586–593. 170 indexed citations
16.
Cass, Lindsey, Constantin Efthymiopoulos, & Alan Bye. (1999). Pharmacokinetics of Zanamivir After Intravenous, Oral, Inhaled or Intranasal Administration to Healthy Volunteers. Clinical Pharmacokinetics. 36(Supplement 1). 1–11. 162 indexed citations
17.
Cass, Lindsey, et al.. (1999). Pharmacoscintigraphic Evaluation of Lung Deposition of Inhaled Zanamivir in Healthy Volunteers. Clinical Pharmacokinetics. 36(Supplement 1). 21–31. 101 indexed citations
18.
Cass, Lindsey, Constantin Efthymiopoulos, Julie Marsh, & Alan Bye. (1999). Effect of Renal Impairment on the Pharmacokinetics of Intravenous Zanamivir. Clinical Pharmacokinetics. 36(Supplement 1). 13–19. 21 indexed citations
19.
Bergström, Mats, Lindsey Cass, Sven Valind, et al.. (1999). Deposition and Disposition of [C]Zanamivir Following Administration as an Intranasal Spray. Clinical Pharmacokinetics. 36(Supplement 1). 33–39. 50 indexed citations
20.
Cass, Lindsey. (1957). A Unique Association of Two Species of Lepidoptera. The Canadian Entomologist. 89(10). 484–484. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimberly Robins Breakdown of academic impact, for papers by Anne L. Hotard Breakdown of academic impact, for papers by R. J. Harris Breakdown of academic impact, for papers by Hilda N. Rivera Breakdown of academic impact, for papers by D Blaškovič Breakdown of academic impact, for papers by Ludmila V. Asher Breakdown of academic impact, for papers by Xiaowang Qu Breakdown of academic impact, for papers by Catherine M. Bendel Breakdown of academic impact, for papers by Gardner Middlebrook Breakdown of academic impact, for papers by E Balestra
Rankless by CCL
2026